Susquehanna International Group
JNP

Susquehanna International Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Susquehanna International Group’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-32,450
Closed -$282K – 10865
2018
Q2 		$282K Sell
32,450
-9,668
-23% -$87K ﹤0.01% 7966
2018
Q1 		$427K Buy
42,118
+29,796
+242% +$250K ﹤0.01% 6959
2017
Q4 		$60K Buy
+12,322
New +$59.9K ﹤0.01% 8866
2016
Q3 		– Sell
-16,946
Closed -$112K – 9418
2016
Q2 		$119K Sell
16,946
-17,746
-51% -$125K ﹤0.01% 7944
2016
Q1 		$229K Buy
34,692
+1,164
+3% +$8.57K ﹤0.01% 7746
2015
Q4 		$345K Sell
33,528
-24,738
-42% -$287K ﹤0.01% 7442
2015
Q3 		$686K Buy
58,266
+19,673
+51% +$217K ﹤0.01% 6499
2015
Q2 		$353K Sell
38,593
-7,431
-16% -$56.1K ﹤0.01% 8267
2015
Q1 		$286K Buy
+46,024
New +$285K ﹤0.01% 8053

Susquehanna International Group's JNP Position: Q3 2018 in Review

Susquehanna International Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 32,450 shares — an estimated $282K sold.

Susquehanna International Group first reported a position in JNP in Q1 2015 and held it in 9 quarters. The position peaked at $686K in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Susquehanna International Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Susquehanna International Group sold 32,450 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $282K.
  • Susquehanna International Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • Susquehanna International Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $686K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.